BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Trading in Novo Nordisk Shares by Board Members, Executives and Associated Persons on 12 February 2018

  The company’s board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated persons.

  February 13, 2018

   · 

  1 min read
• Business

  Executive Chairman of Anthem Inc., Joseph Swedish, Joins the Board of Proteus Digital Health

  Proteus Digital Health announced today that Joseph Swedish, the Executive Chairman of Anthem Inc., has joined its Board of Directors.

  February 13, 2018

   · 

  3 min read
• Biotech Beach

  Daré Bioscience to Raise Approximately $10.25M

  The offering is expected to close on or about February 15, 2018, subject to customary closing conditions.

  February 13, 2018

   · 

  4 min read
• Genetown

  SeraCare Announces Industry’s First CNV-Specific Reference Material for Gene Amplifications in Breast, Lung, and Brain Cancer

  These expert-designed products are built with innovative biosynthetic technology that is easily scalable to incorporate new CNVs over time.

  February 13, 2018

   · 

  4 min read
• Annual General Meeting in ALK-Abelló A/S on 12 March 2018

  The agenda of the meeting including the complete proposals from the Board of Directors to the AGM is attached.

  February 13, 2018

   · 

  1 min read
• Business

  Spark Therapeutics to Host Conference Call on Tuesday, Feb. 20 at 8:30 a.m. ET to Discuss 2017 Results and Recent Business Highlights

  The call can be accessed by dialing (855) 851-4526 (domestic) or (720) 634-2901 (international), and entering passcode 9596288.

  February 13, 2018

   · 

  1 min read
• Conversion of FIT Biotech Oy’s Convertible Capital Notes Into Shares - Feb. 13, 2018

  The Board authorization is based on the Extraordinary General Meeting December 14, 2017.

  February 13, 2018

   · 

  1 min read
• Business

  BerGenBio ASA: Results for the Fourth Quarter and Full Year 2017

  A presentation of the results by the Company’s senior management team will take place today at 10.00 am CET in Oslo - details below.

  February 13, 2018

   · 

  7 min read
• Business

  Moberg Pharma AB Year-End Report 2017

  Net revenue SEK 439.0 million

  February 13, 2018

   · 

  6 min read
• Drug Development

  Chi-Med Completes Enrollment of 527 Patients in Pivotal Phase III FALUCA Trial with Fruquintinib in Lung Cancer

  Chi-Med has completed patient enrollment of FALUCA, its Phase III pivotal trial of fruquintinib in advanced, third-line, non-small cell lung cancer (“NSCLC”) patients in China.

  February 13, 2018

   · 

  6 min read